Intra-Cellular Therapies
ITCI
#1337
Rank
NZ$23.74 B
Marketcap
$223.46
Share price
0.07%
Change (1 day)
94.48%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.83. In 2022 the company made an earnings per share (EPS) of -$4.78 an increase over its 2021 EPS that were of -$6.15.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-45.6%
2022-$4.78-22.29%
2021-$6.158.02%
2020-$5.7020.9%
2019-$4.71-5.63%
2018-$4.9933.96%
2017-$3.73-21.19%
2016-$4.73-7.56%
2015-$5.12174.53%
2014-$1.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.44-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.58 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.76 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA